Oxidative Medicine and Cellular Longevity / 2018 / Article / Tab 5

Research Article

Long-Term Resveratrol Supplementation as a Secondary Prophylaxis for Stroke

Table 5

Effect of resveratrol on glucose.

EvaluationGlucose (mg/dL)
DiabeticsESNondiabeticsES

Resveratrol 100 mg group
Initial142.18 ± 15.2296.67 ± 11.26
At 6 months136.29 ± 14.480.3991.23 ± 10.750.48
At 12 months134.24 ± 14.310.1487.12 ± 10.610.38
Resveratrol 200 mg group
Initial142.46 ± 15.2496.98 ± 11.23
At 6 months136.21 ± 14.560.4191.21 ± 10.670.51
At 12 months133.89 ± 15.680.1686.11 ± 10.780.48
Control group
Initial142.47 ± 15.8395.71 ± 11.63
At 6 months141.81 ± 15.310.0494.55 ± 11.220.10
At 12 months140.58 ± 15.620.0893.33 ± 11.280.11

Values are represented as mean ± SD ( diabetic and nondiabetic patients in the resveratrol 100 mg group; diabetic and nondiabetic patients in the resveratrol 200 mg group; and diabetic and nondiabetic patients in the control group); versus initial value; <0.05 versus control group value.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.